If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
IPO today
Knowbe4, Inc. (KNBE)
Zymergen Inc. (ZY)
Neuropace Inc (NPCE)
Upcoming IPO
Agiliti, Inc (AGTI)
Treace Medical Concepts, Inc. (TMCI)
Latham Group, Inc. (SWIM)
Rain Therapeutics Inc. (RAIN)
Impel Neuropharma, Inc. (IMPL)
Ftc Solar, Inc. (FTCI)
Aveanna Healthcare Holdings Inc. (AVAH)
Endeavor Group Holdings (EDR)
The Fortegra Group, Inc. (FRF)
Privia Health Group, Inc. (PRVA)
Priced IPO
Uipath Inc (PATH)
Doubleverify Holdings, Inc. (DV)
Skywater Technology, Inc. (SKYT)
Infobird (IFBD)
Troika Media Group, Inc. (TRKA)
Biomea Fusion, Inc. (BMEA)
Akoya Biosciences, Inc. (AKYA)
Recursion Pharmaceuticals, Inc. (RXRX)
Karat Packaging Inc. (KRT)
AppLovin (APP)
Esports Technologies (EBET)
Agilon Health, Inc. (AGL)
TuSimple Holdings Inc (TSP)
Coinbase Global, Inc. (COIN)
Alkami Technology, Inc. (ALKT)
Reneo Pharmaceuticals, Inc. (RPHM)
Vectivbio Holding Ag (VECT)
UTime Limited (UTME)
Frontier Group Holdings (ULCC)
Compass, Inc. (COMP)
More companies

Movano (MOVE)

Sector - Healthcare

Price chart

Return from IPO

Company News

IPO Profile

About company

They are a health-focused technology company developing simple, smart and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. They are developing a proprietary platform that uses Radio Frequency ("RF") technology, which they believe will enable the creation of low-cost and scalable sensors that are small enough to fit into a wearable, and other small form factors. They expect that their platform will provide users with the ability to measure and continuously monitor vital health data and provide actionable feedback to jumpstart changes in behaviors. Their platform is the foundation for their first product in development, which is a non-invasive and cuffless wearable that simultaneously measures glucose, blood pressure and heart rate. It is intended to combine the functionality of a continuous glucose monitor ("CGM") and a cuffless RF-based blood pressure monitor ("rBPM") into one wearable device. Once developed, they believe it will allow users to manage their health with confidence and in a manner that best fits their lifestyle, ultimately improving health outcomes.
Electromedical & Electrotherapeutic Apparatus
Michael Leabman Jeremy (“J.”) Cogan
Employees Founded
15 2018


Address: 6200 Stoneridge Mall Rd., Suite 300 Pleasanton, Ca 94588

Telephone: (415) 651-3172

Web page:

IPO information

First Trade Date 3/23/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
Share prices ($)

Shares & Volumes

Shares Initial (MM) 7.2
Shares Revised (MM) 8.5
Expected offer amount (MM) $36
Realized offer amount(MM) $42.5

Financial Data (last reporting year)

Market Cap (MM) $147.75
Revenues (MM) $0
Net Income (Loss) (MM) $-13.0


What do you think will happen with the MOVE share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: National Securities

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
National Securities

Sector: Healthcare

Tweets about $MOVE

Tweets volume:

RT volume:


Google Trends Stats